Wang Wang Selected Research

Wang Wang Research Topics

Disease

19	Neoplasms (Cancer) 12/2021 - 05/2008
15	Heart Failure 01/2021 - 05/2008
14	Hypoxia (Hypoxemia) 10/2021 - 01/2008
12	Inflammation (Inflammations) 03/2021 - 02/2011
8	Pulmonary Hypertension 07/2020 - 09/2013
8	Fibrosis (Cirrhosis) 12/2017 - 02/2011
7	Cardiomegaly (Heart Hypertrophy) 01/2022 - 06/2012
6	Ischemia 01/2022 - 12/2008
6	Myocardial Infarction 01/2022 - 07/2013
6	Cardiovascular Diseases (Cardiovascular Disease) 05/2018 - 01/2012
6	Heart Diseases (Heart Disease) 05/2018 - 11/2008
5	Neointima 05/2022 - 01/2020
5	Cardiomyopathies (Cardiomyopathy) 01/2020 - 03/2014
5	Wounds and Injuries (Trauma) 01/2019 - 05/2005
5	Hypertrophy 01/2018 - 03/2014
4	COVID-19 03/2022 - 01/2021
4	Multiple Myeloma 02/2021 - 09/2017
4	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2015
4	Right Ventricular Hypertrophy 01/2020 - 12/2014
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 09/2015
3	Hyperplasia 12/2022 - 01/2021
3	Tendinopathy (Tendonitis) 01/2021 - 01/2020
3	Insulin Resistance 12/2020 - 03/2014
3	Vascular Remodeling 01/2020 - 12/2015
3	Obesity 01/2020 - 03/2015
3	Hypertension (High Blood Pressure) 01/2019 - 07/2014
3	Infarction (Infarctions) 08/2017 - 09/2015
3	Reperfusion Injury 07/2013 - 11/2008
2	Carcinogenesis 10/2021 - 04/2019
2	Abdominal Aortic Aneurysm 05/2021 - 01/2019
2	Cognitive Dysfunction 01/2021 - 04/2017
2	Pulmonary Arterial Hypertension 01/2020 - 12/2015
2	Vascular Diseases (Vascular Disease) 01/2019 - 01/2012
2	Bronchiectasis 01/2019 - 07/2018
2	Iron Overload 01/2017 - 12/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2016 - 11/2008
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 09/2014 - 07/2011
2	Plague (Bubonic Plague) 10/2010 - 09/2009
2	Shock 01/2008 - 05/2005
1	Osteoarthritis 06/2022

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 03/2022 - 12/2008
6	Protein Isoforms (Isoforms)IBA 01/2022 - 07/2009
6	ApelinIBA 01/2019 - 01/2012
6	Superoxides (Superoxide)IBA 12/2017 - 07/2008
6	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2016 - 01/2008
5	Pharmaceutical PreparationsIBA 12/2022 - 03/2014
5	Sirolimus (Rapamycin)FDA Link 12/2022 - 12/2014
5	CateninsIBA 02/2021 - 01/2013
5	Peptides (Polypeptides)IBA 10/2019 - 01/2012
5	CalciumIBA 01/2016 - 07/2009
4	EnzymesIBA 11/2021 - 01/2016
4	Glucose (Dextrose)FDA LinkGeneric 03/2021 - 01/2013
4	Angiotensin IIIBA 01/2019 - 02/2011
4	Therapeutic UsesIBA 12/2015 - 01/2012
3	Proliferating Cell Nuclear Antigen (PCNA)IBA 05/2022 - 05/2021
3	Adenosine Triphosphate (ATP)IBA 01/2022 - 09/2015
3	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2022 - 11/2008
3	Interleukin-17 (Interleukin 17)IBA 11/2021 - 01/2019
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 07/2021 - 05/2008
3	IronIBA 06/2021 - 12/2015
3	Angiotensin-Converting Enzyme 2IBA 12/2017 - 02/2011
3	Polysaccharides (Glycans)IBA 05/2017 - 07/2015
3	Matrix Metalloproteinases (MMPs)IBA 12/2014 - 07/2014
3	NADPH Oxidases (NAD(P)H oxidase)IBA 08/2014 - 07/2011
2	HydrogelsIBA 12/2022 - 05/2021
2	AntigensIBA 01/2022 - 09/2021
2	NestinIBA 10/2021 - 01/2020
2	ElastinIBA 10/2021 - 05/2021
2	AntioxidantsIBA 10/2021 - 01/2008
2	Transcription Factors (Transcription Factor)IBA 10/2021 - 03/2014
2	Biological ProductsIBA 06/2021 - 01/2021
2	oridoninIBA 06/2021 - 09/2018
2	MicroRNAs (MicroRNA)IBA 02/2021 - 09/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2017
2	LigandsIBA 01/2021 - 12/2015
2	Proteasome InhibitorsIBA 01/2021 - 11/2020
2	Messenger RNA (mRNA)IBA 12/2020 - 07/2014
2	Oxidoreductases (Dehydrogenase)IBA 12/2020 - 06/2013
2	Phosphates (Orthophosphate)IBA 01/2020 - 12/2015
2	MonocrotalineIBA 01/2020 - 12/2015
2	Neprilysin (Neutral Endopeptidase)IBA 01/2019 - 01/2016
2	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2019 - 01/2018
2	CytokinesIBA 01/2019 - 10/2016
2	FollistatinIBA 01/2018 - 01/2017
2	Mitogen-Activated Protein KinasesIBA 01/2018 - 09/2014
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2018 - 05/2008
2	AngiotensinsIBA 12/2017 - 01/2012
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 01/2012
2	Metalloproteases (Metalloproteinases)IBA 01/2016 - 09/2015
2	Cyclin D1IBA 12/2015 - 01/2013
2	Mitochondrial Permeability Transition PoreIBA 09/2015 - 07/2008
2	Subunit VaccinesIBA 10/2010 - 09/2009
1	AlginatesIBA 12/2022
1	Hyaluronic Acid (Hyaluronan)IBA 12/2022
1	RhodaminesIBA 12/2022
1	rhyncophyllineIBA 06/2022
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 05/2022

Therapy/Procedure

14	Therapeutics 12/2021 - 05/2008
2	Ovariectomy (Oophorectomy) 01/2022 - 01/2017
2	Intraperitoneal Injections 01/2021 - 01/2020